When a nagging injury refuses to heal, patients usually run through the same familiar list of options: rest, ice, stretching, maybe a steroid injection or two, and if none of that works, surgery. That pathway works well for acute injuries that just need time. Still, it consistently fails for chronic soft-tissue conditions like plantar fasciitis, tennis elbow, Achilles tendinopathy, and calcific shoulder tendinitis. A significant share of patients end up stuck in month eight or month fourteen of pain they were told would resolve in six weeks.
Shockwave therapy is one of the treatments that sits between conservative care and surgery in that middle zone where most chronic pain patients actually live. It’s a non-invasive, in-office procedure that uses pulsed acoustic energy to trigger the body’s own healing response in tissue that hasn’t been repairing itself. The technology has been around in orthopedic settings for more than two decades, has FDA clearance for several common conditions, and is increasingly offered by chiropractic and sports medicine clinics across the Chicago suburbs.
Patients seeking shockwave therapy have several providers to choose from, including offices such as True Health Chiropractic and Acupuncture in Lombard, as well as a handful of other clinics serving the western suburbs. What follows is what the procedure actually does, what conditions it treats well, what it doesn’t do, and how to think about whether it’s the right fit for a specific pain problem.
What is Shockwave Therapy
The formal name is extracorporeal shockwave therapy, or ESWT. The version most commonly used in outpatient clinics is radial pressure wave therapy, which delivers lower-energy acoustic pulses through a handheld applicator pressed against the skin. A gel is applied first, the applicator moves over the painful area in a circular pattern, and pulses are delivered for roughly 5 to 10 minutes per session.
The pulses create microtrauma in damaged tissue. That controlled injury triggers increased blood flow, the release of growth factors, the breakdown of calcium deposits in tendons, and the recruitment of regenerative cells to the area. The body essentially gets a signal to restart healing on tissue that had given up.
The treatment originated from lithotripsy, the technology used to break up kidney stones, and was adapted for orthopedic use in Germany in the 1990s. It’s now used globally and has a strong body of published research supporting its use for several specific conditions.
Conditions with the Strongest Evidence
Not every pain problem responds to shockwave. The research is much stronger for some conditions than others.
Plantar fasciitis is the best-studied application. The American Academy of Orthopedic Surgeons’ information on plantar fasciitis and bone spurs lists ESWT as an option for patients whose heel pain hasn’t resolved with months of conservative treatment. Multiple randomized trials show meaningful reductions in pain and improvements in function, especially for chronic cases that haven’t responded to stretching, orthotics, or night splints.
Other conditions with supporting evidence include lateral epicondylitis (tennis elbow), medial epicondylitis (golfer’s elbow), calcific tendinitis of the shoulder, Achilles tendinopathy, patellar tendinopathy (jumper’s knee), and trochanteric pain syndrome at the hip. Published orthopedic reviews report success rates for these conditions ranging from 65% to 91%, depending on the specific indication and protocol.
The Session
Patients generally describe shockwave treatment as uncomfortable but tolerable. The pulses produce a rapid tapping sensation that can be intense over tender areas, especially in the first minute before the local tissue adjusts. Experienced clinicians adjust intensity throughout the session based on patient feedback.
A standard protocol is three to six sessions, spaced about a week apart. Each session runs 5 to 15 minutes. No anesthesia is needed. Patients walk in, get treated, and walk out. Most can return to work the same day.
Minor side effects are common and mild: temporary redness, slight bruising, and some soreness in the treated area for 24 to 48 hours.
Who Should Consider it?
The best candidates for shockwave are patients with a chronic tendinopathy or fasciopathy (pain lasting 3 to 6 months or longer), a specific diagnosis rather than vague regional pain, a history of trying at least one round of conservative care without full resolution, and a preference for non-invasive options before considering steroid injections or more intensive interventions, such as plantar fasciitis surgery.
Poor candidates include patients with acute injuries that would benefit more from rest and time, patients with joint-space problems like arthritis that aren’t in soft tissue, and patients expecting a one-session fix.
What to Ask Before Booking
Before scheduling shockwave therapy, ask directly:
What specific condition is being treated, and what’s the evidence base for shockwave in that condition? What device is the clinic using, and is it FDA-cleared for the condition? How many sessions are recommended, and what’s the total cost? Does insurance cover shockwave for this indication? For most conditions and most insurers, the answer is no.
What happens if there’s no improvement? A responsible clinic will have a plan for that conversation and won’t keep billing indefinitely for a treatment that isn’t working.
